SCHEMBL7988035

SCHEMBL7988035

CNCc1nc(O)c2c(ncn2Cc2ccc(C)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 2/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
HTT P42858 1/20 0.39
CTSL P07711 2/20 0.37
HPGD P15428 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NR3C1 P04150 2/20 0.35
YTHDC1 Q96MU7 2/20 0.33
MET P08581 2/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
BRD4 O60885 1/20 0.32
CTSB P07858 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7988141 0.99 SMN1; SMN2 (0.39) SMN1; SMN2LMNACYP11B1CYP11B2HTT
SCHEMBL7985513 0.89 MET (0.43) SMN1; SMN2CYP11B1CYP11B2HTTCTSL
SCHEMBL7984365 0.89 HPGD (0.45) SMN1; SMN2CYP11B1CYP11B2CTSLHPGD
Hydrochloric Acid SCHEMBL7988731 0.88 MET (0.42) SMN1; SMN2CYP11B1CYP11B2HTTCTSL
Hydrochloric Acid SCHEMBL7992066 0.88 HPGD (0.44) SMN1; SMN2CYP11B1CYP11B2CTSLHPGD
SCHEMBL7991685 0.87 ABCC8 (0.44) SMN1; SMN2CYP11B1CYP11B2HPGDALDH1A1
Hydrochloric Acid SCHEMBL7985465 0.86 ABCC8 (0.43) SMN1; SMN2CYP11B1CYP11B2HPGDALDH1A1
SCHEMBL7988356 0.86 ALDH1A1 (0.44) SMN1; SMN2LMNACYP11B1CYP11B2HTT
SCHEMBL7987434 0.86 CYP11B1 (0.42) SMN1; SMN2LMNACYP11B1CYP11B2HTT
SCHEMBL7989377 0.85 LMNA (0.44) SMN1; SMN2LMNACYP11B1CYP11B2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed